Gilead Sciences



Ebitda تغيير تاريخ
AbbVie USD 6.92B 258M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 222.66M 97.54M 2025-03
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.12B 1.06B 2024-12
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Sanofi EUR 2.86B 2.3B 2025-03
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
United Therapeutics USD 402.6M 19.2M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Gilead Sciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.